908 Devices Stock

908 Devices EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of 908 Devices (MASS) as of Jul 25, 2026 is -9.71. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -3.06 — a change of 217.28% (lower).

EV/EBIT

-9.71

YoY

217.28%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of 908 Devices is 2026 -9.71 . EV/EBIT (Enterprise Value to EBIT) of 908 Devices was 2025 -3.06 . It decreases by 217.28% lower compared to the previous year.

The 908 Devices EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

PRICE-TO-EBIT
Date
PRICE-TO-EBIT
Jan 1, 2019
0.00 base
Jan 1, 2020
-230.04 base
Jan 1, 2021
-35.17 base
Jan 1, 2022
-6.84 base
Jan 1, 2023
-8.51 base
Jan 1, 2024
-0.99 base
Jan 1, 2025
-8.45 base
Jan 1, 2026 (e)
-16.25 base
YEARPRICE-TO-EBIT
2026 est -16.25
2025 -8.45
2024 -0.99
2023 -8.51
2022 -6.84
2021 -35.17
2020 -230.04
2019 -
2018 -
Access this data via the Eulerpool API

908 Devices Valuation

Details

Historical Valuation Multiples

Price-to-Earnings Ratio (P/E)

The P/E ratio divides 908 Devices's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates 908 Devices's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots 908 Devices's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if 908 Devices grows earnings faster than its peers.

908 Devices Stock analysis

What does 908 Devices do? The company 908 Devices was founded in Boston in 2012 and specializes in the development and manufacturing of innovative analysis devices. The idea behind the company was to develop portable devices that would allow users to perform quick and accurate analyses on-site. 908 Devices' business model is based on the development and marketing of devices for the chemistry, pharmaceutical, and biotech industries, as well as for applications in the security and defense sectors. The company has several product lines tailored to different applications, including portable devices for mobile use. One of the most important branches of 908 Devices is mass spectrometry, a method used in many areas of analytics, such as forensics, environmental analysis, and food control. 908 Devices has developed a technology that allows for compact and portable mass spectrometry, which was not previously possible. Another important area of 908 Devices is chromatography, a method used for separating substances. Here too, the company has developed a technology that allows for the offering of chromatography in portable devices. 908 Devices also offers devices for molecular spectroscopy, including Raman spectroscopy, which allows for the identification and characterization of molecules. Raman spectroscopy is used in many applications, such as pharmaceutical research and material analysis. Among the products offered by 908 Devices are the M908 and MX908 devices, specifically designed for use in the security and defense industry. These devices allow for the real-time detection of a variety of hazardous substances, such as explosives, drugs, or dangerous chemicals. Another product of 908 Devices is the ZipChip device, used in biotech research. The ZipChip allows for the analysis of proteins in a very short time, which is of great importance in pharmaceutical research. The company has received several awards in recent years, including the R&D 100 Award and the Innovation Award of Analytica, one of the world's most important trade fairs for analytics and laboratory technology. Overall, 908 Devices has achieved an impressive success story and aims to revolutionize the way analyses are conducted. With its innovative products and technologies, the company has found a niche in the market and has experienced strong growth. 908 Devices is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 908 Devices stock

EV/EBIT (Enterprise Value to EBIT) of 908 Devices is -9.71 in 2026.

Access this data via the Eulerpool API

Valuation — 908 Devices

All Key Metrics — 908 Devices